Aurobindo Pharma witnessed a nearly 9% surge in consolidated net profit for Q2FY25, reaching Rs 817 crore. This growth was fueled by an 8% rise in consolidated revenue, driven by a strong ...

Aurobindo Pharma consolidated net profit for the September quarter increased 8.6% to ₹816.9 crore compared to ₹751.9 crore year earlier. On a sequential basis the net profit was 11% lower ...

Hyderabad-based Aurobindo Pharma has registered a growth of 8.6 per cent in net profit for the quarter ended September 30, 2024 at Rs. 816.95 crore as compared to Rs. 751.94 crore during the same ...

Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has received a GMP certificate from the European Medicines Agency for its ...

Aurobindo Pharma witnessed an 8.6% YoY increase in net profit, reaching Rs 817 crore in Q2 FY25, driven by robust sales in Europe and growth markets. Despite a dip in US formulations revenue, the ...

AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2024 inter alia to consider and approve Intimation of Board meeting to be held on ...

Aurobindo Pharma Ltd on Wednesday said it will acquire the balance 49 per cent stake in GLS Pharma Ltd for Rs 22.5 crore to make the latter a wholly-owned subsidiary. Intimation of entering into a ...

Here’s a quick look at stocks likely to be in focus in today's trade.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on ...

Revenue 29,001.87 24,855.38 23,455.49 24,774.62 ...

The same stood at Rs 440.6 crore in the corresponding quarter last fiscal. Aurobindo Pharma on Tuesday said its unit has ...